165 related articles for article (PubMed ID: 15544747)
1. [From efficacy to effectiveness in the secondary prevention of coronary heart disease].
Brotons Cuixart C
Rev Esp Cardiol; 2004 Nov; 57(11):1007-8. PubMed ID: 15544747
[No Abstract] [Full Text] [Related]
2. Evidence based secondary prevention of coronary artery disease in the elderly--2006.
García-Palmieri MR
P R Health Sci J; 2006 Sep; 25(3):229-39. PubMed ID: 17203793
[TBL] [Abstract][Full Text] [Related]
3. [Secondary prevention and the rehabilitative therapy of patients with different forms of coronary pathology. The individual approach and criteria for determining efficacy].
Karpov RS
Ter Arkh; 1995; 67(8):34-6. PubMed ID: 7482330
[No Abstract] [Full Text] [Related]
4. [An update on the medical therapy of chronic coronary disease].
Morais J
Rev Port Cardiol; 1999 Sep; 18 Suppl 4():IV9-15. PubMed ID: 10555448
[No Abstract] [Full Text] [Related]
5. [New trends in the pharmaceutical treatment of chronic coronary heart disease].
Shi ZW
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jul; 33(7):663-5. PubMed ID: 16080824
[No Abstract] [Full Text] [Related]
6. [Secondary prevention of ischemic heart disease: a struggle on 2 fronts].
Verheugt FW
Ned Tijdschr Geneeskd; 1992 Jul; 136(29):1392-6. PubMed ID: 1641047
[No Abstract] [Full Text] [Related]
7. [Epidemiology and prevention of cardiovascular diseases].
Jánosi A
Orv Hetil; 2005 Apr; 146(15):683-8. PubMed ID: 15895792
[TBL] [Abstract][Full Text] [Related]
8. Reassessing the validity of surrogate markers of drug efficacy in the treatment of coronary artery disease.
Colatsky TJ
Curr Opin Investig Drugs; 2009 Mar; 10(3):239-44. PubMed ID: 19333881
[TBL] [Abstract][Full Text] [Related]
9. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.
Smith SC; Allen J; Blair SN; Bonow RO; Brass LM; Fonarow GC; Grundy SM; Hiratzka L; Jones D; Krumholz HM; Mosca L; Pasternak RC; Pearson T; Pfeffer MA; Taubert KA; ;
Circulation; 2006 May; 113(19):2363-72. PubMed ID: 16702489
[No Abstract] [Full Text] [Related]
10. New thrombin inhibiting strategies for coronary artery disease.
Shah PK; Parikh A
Indian Heart J; 1995; 47(4):381-6. PubMed ID: 8557285
[No Abstract] [Full Text] [Related]
11. Calcium channel blockers and coronary heart disease.
Inzitari M; Di Bari M; Marchionni N
Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):6-15. PubMed ID: 16640169
[TBL] [Abstract][Full Text] [Related]
12. [The primary prevention of ischemic cardiopathy. What is the place of pharmacological intervention?].
Corral Corral C
Med Clin (Barc); 1991 Mar; 96(10):388-93. PubMed ID: 2046417
[No Abstract] [Full Text] [Related]
13. Interpreting clinical trials: the 'beautiful' case.
Agewall S; Atar D
Fundam Clin Pharmacol; 2009 Apr; 23(2):261-2. PubMed ID: 19236485
[No Abstract] [Full Text] [Related]
14. Drug-eluting stents and the future of coronary artery bypass surgery: facts and fiction.
Raja SG
Ann Thorac Surg; 2006 Mar; 81(3):1162-71. PubMed ID: 16488758
[TBL] [Abstract][Full Text] [Related]
15. Secondary prevention of arterial disease in very elderly people: results from a prospective registry (FRENA).
López-Jiménez L; Camafort M; Tiberio G; Carmona JA; Guijarro C; Martínez-Peñalver F; Monreal M;
Angiology; 2008; 59(4):427-34. PubMed ID: 18388061
[TBL] [Abstract][Full Text] [Related]
16. Economic issues in coronary heart disease prevention in India.
Gupta R; Prakash H; Gupta RR
J Hum Hypertens; 2005 Aug; 19(8):655-7. PubMed ID: 15829996
[No Abstract] [Full Text] [Related]
17. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
[TBL] [Abstract][Full Text] [Related]
18. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS-II): prologue to COURAGE.
King SB
Circulation; 2007 Mar; 115(9):1064-6. PubMed ID: 17339563
[No Abstract] [Full Text] [Related]
19. [Problems in long-term therapy of coronary heart disease: clinical aspects].
Stauch M; Schmidt A; Kress P
Med Klin (Munich); 1987 Jan; 1():24-8. PubMed ID: 3106751
[No Abstract] [Full Text] [Related]
20. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
